Last reviewed · How we verify
Pf-08046032 (pf-08046032)
At a glance
| Generic name | pf-08046032 |
|---|---|
| Sponsor | Pfizer |
| Drug class | Unknown pharmacological class |
| Target | Unknown target |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Indication not found
- Indication not found
Common side effects
Drug interactions
- Warfarin
- Aspirin
- Pentobarbital
- Phenobarbital
- Rivaroxaban
- Apixaban
- Dabigatran
- Clopidogrel
- Ticagrelor
- Prasugrel
- Cilostazol
- Dipyridamole
Key clinical trials
- A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |